Evelo Biosciences, Inc. Profile Avatar - Palmy Investing

Evelo Biosciences, Inc.

Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase…

Biotechnology
US, Cambridge [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Evelo Biosciences, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Evelo Biosciences, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Evelo Biosciences, Inc..

End of EVLO's Analysis
CIK: 1694665 CUSIP: 299734103 ISIN: US2997342025 LEI: - UEI: -
Secondary Listings
EVLO has no secondary listings inside our databases.